23 Aug 2025 August 23, 2025 FDA Approves Papzimeos for Adults With Recurrent Respiratory Papillomatosis 23 Aug 2025 FDA approvals August 23, 2025 FDA Approves Papzimeos for Adults With Recurrent Respiratory Papillomatosis Read more
20 Aug 2025 August 20, 2025 FDA Approves Sublingual, Nonopioid Daily Treatment for Fibromyalgia 20 Aug 2025 FDA approvals August 20, 2025 FDA Approves Sublingual, Nonopioid Daily Treatment for Fibromyalgia Read more
18 Aug 2025 August 18, 2025 FDA Approves Ketamine Product, KETARx, for Surgical Pain Management 18 Aug 2025 FDA approvals August 18, 2025 FDA Approves Ketamine Product, KETARx, for Surgical Pain Management Read more
11 Aug 2025 August 11, 2025 FDA Approves Ajovy for Migraine Prevention in Children and Teens 11 Aug 2025 FDA approvals August 11, 2025 FDA Approves Ajovy for Migraine Prevention in Children and Teens Read more
7 Aug 2025 August 7, 2025 FDA Approves SetPoint Neuroimmune Modulation Device for Rheumatoid Arthritis 7 Aug 2025 FDA approvals August 7, 2025 FDA Approves SetPoint Neuroimmune Modulation Device for Rheumatoid Arthritis Read more
6 Aug 2025 August 6, 2025 FDA Approves Vizz Eye Drops to Improve Near Vision in Adults 6 Aug 2025 FDA approvals August 6, 2025 FDA Approves Vizz Eye Drops to Improve Near Vision in Adults Read more
24 Jul 2025 July 24, 2025 FDA Approves First Cream for Treating Chronic Hand Eczema 24 Jul 2025 FDA approvals July 24, 2025 FDA Approves First Cream for Treating Chronic Hand Eczema Read more
21 Jul 2025 July 21, 2025 FDA Approves Prefilled Syringe Presentation for Shingles Vaccine 21 Jul 2025 FDA approvals July 21, 2025 FDA Approves Prefilled Syringe Presentation for Shingles Vaccine Read more
14 Jul 2025 July 14, 2025 Kerendia Approved for Heart Failure With Left Ventricular Ejection Fraction =40 Percent 14 Jul 2025 FDA approvals July 14, 2025 Kerendia Approved for Heart Failure With Left Ventricular Ejection Fraction =40 Percent Read more
30 Jun 2025 June 30, 2025 FDA Approves Benlysta Autoinjector for Pediatric Patients With Active Lupus Nephritis 30 Jun 2025 FDA approvals June 30, 2025 FDA Approves Benlysta Autoinjector for Pediatric Patients With Active Lupus Nephritis Read more
